Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity

Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.

6,726 public trials 634 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity trial results

Active, Not Recruiting

Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age

NCT05741476

Conditions
Allergy, Peanut, Food Hypersensitivity, Hypersensitivity, +4 more
Locations
  • DBV Investigative Site Birmingham, Alabama, United States
  • DBV Investigative Site Tucson, Arizona, United States
  • DBV Investigative Site Little Rock, Arkansas, United States
  • DBV Investigative Site Los Angeles, California, United States
View all 87 locations
View Trial Details
Active, Not Recruiting

Dose Escalation Trial Of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary Clinical Activity of Briquilimab In Adult Patients With Chronic Spontaneous Urticaria (CSU)

NCT06162728

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +13 more
Locations
  • Site 118 Birmingham, Alabama, United States
  • Site 108 Little Rock, Arkansas, United States
  • Site 105 San Diego, California, United States
  • Site 113 Miami, Florida, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents

NCT05347771

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Children's Hospital Colorado: Allergy Program Aurora, Colorado, United States
  • Children's National Medical Center: Children's Research Institute Washington D.C., District of Columbia, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago: Division of Allergy and Immunology Chicago, Illinois, United States
  • Boston Children's Hospital: Department of Immunology Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD)

NCT03428646

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • Regeneron Investigational Site Birmingham, Alabama, United States
  • Regeneron Investigational Site Gilbert, Arizona, United States
  • Regeneron Investigational Site Fountain Valley, California, United States
  • Regeneron Investigational Site Laguna Hills, California, United States
View all 99 locations
View Trial Details

Related conditions